FDA approval of generic ARVs
1 December 2010. Related: Treatment access.
Treatment access
Europe! HANDS OFF OUR MEDICINE
1 December 2010. Related: Treatment access.
DNP+ president uses 5ml of blood to meet Carla Bruni-Sarkozy
1 December 2010. Related: Treatment access.
Medicines Patent Pool: first research funder announced
1 December 2010. Related: Treatment access.
FDA approval of generic ARVs
1 October 2010. Related: Treatment access.
IAS highlight funding shortfall crisis for Global Fund
1 October 2010. Related: Treatment access.
The need for expanded access to experimental medicines for drug-resistant TB
1 October 2010. Related: Treatment access.
Indian activists challenge proposed EU tradeagreements: Global access to Indian generic ARVs threatened
1 October 2010. Related: Treatment access.
Russian HIV activists arrested in Red Square for protesting drug stock-outs
1 October 2010. Related: Treatment access.
Chinese HIV positive activist Tian Xi to go on trial on trumped up charges
1 October 2010. Related: Treatment access.
US waiting lists increase by over 300% in five months
1 October 2010. Related: Treatment access.
Raltegravir approved inScotland
26 August 2010. Related: Antiretrovirals, Treatment access.
Atazanavir/r approved in Europefor children aged 6 to 18 years
26 August 2010. Related: Antiretrovirals, Treatment access, Paediatric care.
FDA finally approves 4th generation HIV Ag/Ab test in the US
26 August 2010. Related: Antiretrovirals, Treatment access, Pregnancy, Paediatric care, Diagnostics.
FDA approval of generic ARVs
26 August 2010. Related: Treatment access.
FDA approval of generic ARVs
1 June 2010. Related: Treatment access.
U.S. government leading backlash against AIDS funding
1 June 2010. Related: Treatment access.
Evidence from six countries confirms fears of People Living With HIV/AIDS: treatment rationing is escalating
1 June 2010. Related: Treatment access, Treatment advocacy.
Launch of the 10th funding round and other outcomes from the Global Fund
1 June 2010. Related: Treatment access.
FDA approval of generic ARVs
2 April 2010. Related: Treatment access.
Waiting lists grow in the US
2 April 2010. Related: Treatment access.
South African antiretroviral treatment guidelines (2010)
2 April 2010. Related: Treatment access, Guidelines.
Tenofovir registered in Russia
2 April 2010. Related: Treatment access.
MSF criticise Abbott over new ritonavir formulation
2 April 2010. Related: Treatment access.
FDA approval of generic ARVs
6 February 2010. Related: Treatment access.
UNITAID decision to fund patent pool to boost access to new medicines
6 February 2010. Related: Treatment access.
PEPFAR launches five-year strategy
6 February 2010. Related: Treatment access.
Global Fund approves US$2.4 billion in new grants
6 February 2010. Related: Treatment access.
AIDS and mortality in South Africa
30 December 2009. Related: Treatment access.
Punishing success in tackling AIDS: funders retreat could wipe out health gains in HIV affected countries
30 December 2009. Related: Treatment access.
FDA approval of generic ARVs
30 December 2009. Related: Treatment access.
Five-year survival rates of 87% without routine CD4 or laboratory monitoring in DART study demonstrate an important model for ARV access programmes
23 August 2009. Related: Conference reports, Treatment access.
Access to HIV treatment for UK prisoners
3 June 2009. Related: Treatment access, BHIVA news.
Lost benefit of ARVs in South Africa
10 February 2009. Related: Treatment access.
FDA approval of generic ARVs
26 December 2008. Related: Treatment access.
Brazil rejects Gilead patent on tenofovir
30 October 2008. Related: Treatment access.
PEPFAR bill may lift US HIV travel and residency ban
30 October 2008. Related: Treatment access.
Atripla to be licensed in Latin America and the Asia-Pacific region
30 October 2008. Related: Treatment access.
FDA approval of generic ARVs
24 October 2008. Related: Treatment access.
PEPFAR funding bill authorised by the US Senate
8 October 2008. Related: Treatment access.
FDA approval of generic ARVs
30 August 2008. Related: Treatment access.
Access to generic efavirenz in South Africa: MSD agrees to grant licenses on reasonable terms
30 August 2008. Related: Treatment access.
Reaching 3 by 5…by 7: new report on universal access
30 August 2008. Related: Treatment access.
Oxfam criticises DFID’s new strategy as a “missed opportunity”
30 August 2008. Related: Treatment access.
Utility of routine viral load, CD4 count and clinical monitoring among HIV-positive adults in rural Uganda
12 June 2008. Related: Conference reports, Treatment access.
Implementation of more complex regimens for prevention of mother-to-child transmission of HIV in Rwanda
12 June 2008. Related: Conference reports, Treatment access.
The estimated cost of switching from d4T to TDF in South Africa
12 June 2008. Related: Conference reports, Treatment access.
Key patient safety concern removed in new FDA guidance for non-US trials
12 June 2008. Related: Treatment access.
FDA approval of generic ARVs
12 June 2008. Related: Treatment access.
New PMTCT guidelines for South Africa (Feb 2008)
1 April 2008. Related: Treatment access.
Boehringer fails to register tipranavir in Brazil after using Brazilian patients in registrational study
1 February 2008. Related: Antiretrovirals, Treatment access.
HIV and TB co-infection and treatment charges in the UK
1 December 2007. Related: Treatment access, TB coinfection.
Donor governments pledge record amounts to the Global Fund
2 October 2007. Related: Treatment access.
Survival of HIV-positive IDUs in the era of HAART
2 October 2007. Related: Treatment access.
Mbeki draws international scorn for firing deputy health minister
3 September 2007. Related: Treatment access.
Lesotho to revise national guidelines to include tenofovir first line
3 September 2007. Related: Treatment access.
International AIDS treatment advocacy group says overhaul needed to reach new G8 treatment goals
3 September 2007. Related: Treatment access.
Indian court ruling in Novartis case protects India as the pharmacy of the developing world
3 September 2007. Related: Treatment access.
Abbott drops lawsuit against community action
3 September 2007. Related: Treatment access.
G8 pledges to Africa are insufficient
3 July 2007. Related: Treatment access.
Abbott sues ACT-UP Paris
3 July 2007. Related: Treatment access.
UKs DFID support of Thailand
3 July 2007. Related: Treatment access.
Roche patent for hepatitis C drug challenged in India
3 July 2007. Related: Treatment access.
New PK data for protease inhibitors
4 May 2007. Related: Conference reports, Treatment access, Paediatric care, Guidelines.
Clinton Foundation announces significant price reductions for generic second-line drug and more tolerable first-line options
4 May 2007. Related: Treatment access.